Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation

Epilepsia
W D HooperM J Eadie

Abstract

We assessed the effects of felbamate (FBM) on the disposition of valpr oic acid (VPA) in healthy volunteer men. Eighteen subjects received sodium VPA, 400 mg/day for 21 days. Plasma and urine samples were taken on day 7 to document the steady-state disposition of VPA alone. From day 8 to day 21, subjects received placebo or FBM at the following doses (mg/day): 1,200, 2,400, 3,000, or 3,600 (n = 2-4 per group). Many adverse events (AE) occurred from about day 10; 2 subjects dropped out and 1 continued on a reduced FBM dose. Pharmacokinetic studies were repeated on day 21 for the 16 subjects who completed the study. FBM was measured in plasma and urine by high-performance liquid chromatography (HPLC). VPA and its 2-en, 4-en, and 3-oxo metabolites in plasma, and VPA (nonconjugated and total), and its 3-oxo and 4-hydroxy metabolites in urine were measured by gas chromatography/mass spectrometry (GC/MS). Mean plasma FBM trough concentrations on day 21 ranged from 26.9 mu g/ml (1,200 mg dose) to 76.8 mu g/ml (3,600-mg dose). Mean plasma VPA C max values were 32-42 mu g/ml in the various subgroups when VPA only was administered. Higher plasma VPA levels were observed when FBM was administered concurrently (55.4-63.8 mu g/ml). The excr...Continue Reading

References

Jan 1, 1989·Therapeutic Drug Monitoring·R G DickinsonM J Eadie
Jan 1, 1989·Journal of Drug Education·T M Manning, K C Banfield
Jul 1, 1984·The British Journal of Nutrition·M Krotkiewski
Nov 1, 1994·Clinical Pharmacology and Therapeutics·M L WagnerJ L Perhach
Nov 26, 1993·The Medical Letter on Drugs and Therapeutics
May 1, 1993·Clinical Pharmacology and Therapeutics·M L WagnerI E Leppik

❮ Previous
Next ❯

Citations

Apr 29, 1998·Journal of Clinical Pharmacology·R C SachdeoA Rosenberg
Apr 1, 1997·Epilepsy Research·B E GidalG L Lensmeyer
Apr 16, 2002·Epilepsia·Philip N PatsalosClementina M van Rijn
Sep 9, 2005·Epilepsia·Jorge A González-MartínezWilliam E Bingaman
Oct 2, 2008·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Tominaga FukazawaYohei Miyamoto
Apr 17, 2001·Biopharmaceutics & Drug Disposition·R S AddisonR G Dickinson
Oct 13, 2000·Fundamental & Clinical Pharmacology·M S Benedetti
Dec 22, 1999·Therapeutic Drug Monitoring·M ContinA A Baruzzi
May 27, 2003·Therapeutic Drug Monitoring·Svein I JohannessenPhilip N Patsalos
Jun 2, 2015·Expert Opinion on Drug Metabolism & Toxicology·Anna FerrariEmilio Sternieri
Aug 12, 2010·Thérapie·Danièle Bentué-FerrerUNKNOWN Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique
Mar 9, 2010·Thérapie·Olivier TributUNKNOWN le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique
May 23, 2015·Case Reports in Psychiatry·James JacksonJose de Leon
Apr 9, 1998·The Annals of Pharmacotherapy·K B TallianC Y Tsao
Oct 29, 2008·Neuropsychology Review·Lauren KenworthyGregory L Wallace
Feb 5, 2008·International Urology and Nephrology·H Nandeesha
Apr 13, 2004·The Journal of Pharmacology and Experimental Therapeutics·Andrew W E Wright, Ronald G Dickinson
Jun 2, 1998·The Annals of Pharmacotherapy·G D Anderson
Oct 26, 1999·Epilepsia·J M Pellock
Apr 2, 2019·Current Pharmaceutical Design·Hong-Li GuoTengfei Wang
Apr 14, 2017·CNS Drugs·Peer Tfelt-HansenJacob Tfelt-Hansen
Mar 15, 2001·Chronobiology International·D M ReithD McLaughlin
May 3, 2000·British Journal of Clinical Pharmacology·D B McLaughlinR G Dickinson
Aug 22, 2001·Biopharmaceutics & Drug Disposition·D M ReithM J Eadie
Sep 2, 2021·International Journal of Bipolar Disorders·Sean Bennett, Mujeeb U Shad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinica Chimica Acta; International Journal of Clinical Chemistry
T KuharaN Sakura
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
G R GrannemanJ W Kesterson
© 2021 Meta ULC. All rights reserved